Fundraising Fox
/People
Sign in

Graham Walmsley

Investor

Managing Partner at Logos

New York, New York, United States

Find your path to Graham

280 people in our graph share verified history with Graham — schools, employers, funds. One of them is your warm intro.

David AllisonunlockedGraham: together at Versant Ventures (2016)
×11Graham: together at Versant Ventures

About

Graham Walmsley is a Managing Partner at Logos Capital, where he works on the firm's private investments and structured public investing. He was previously a Principal and Portfolio Manager of the Vantage crossover fund at Versant Ventures, where he served as a board director and helped build biotechnology companies including BlueRock Therapeutics and Akero Therapeutics, and led business development for Jecure Therapeutics. He has authored more than 60 peer-reviewed publications and holds an MD and PhD from Stanford University School of Medicine.

Contact· self-published, not guessed

Invests in

Biotech

Experience

  1. Logos Global Management, LPCo-Founder & Managing Partnercurrent2019 — presentNew York, New York, United States
  2. Olema OncologyBoard Director (NASDAQ: OLMA)current2020 — presentSan Francisco Bay Area
  3. Akero TherapeuticsBoard Director (NASDAQ: AKRO)2018 — 2025Boston, MA
  4. 35PharmaBoard Director2023 — 2024Montreal, QC
  5. Versant VenturesPrincipal2016 — 2019San Francisco Bay Area
  6. BlueRock TherapeuticsBoard Observer2016 — 2019Greater Boston
  7. Jecure TherapeuticsHead of Business Development2017 — 2019San Diego County, CA
  8. Stanford Hospital & ClinicsAffiliated Trainee2012 — 2016San Francisco Bay Area

Skills & more

Hedge Funds36Private Equity48Healthcare56Investment Management7Equities6

From Graham's professional profile.

Investments

Led

Jecure Therapeutics

Board seats

Akero TherapeuticsOlema Pharmaceuticals

Investor

BlueRock Therapeutics

Per the firm's website.

Colleagues at Logos

Arsani William
Managing Partner, CIO at Logos
Benjamin Chan
Finance Manager at Logos
Brandon Adams
Analyst at Logos
Cynthia Goldsmith
Chief Financial Officer at Logos
Derek Gould
General Counsel / Chief Compliance Officer at Logos
Dr. Arsani William
Managing Partner / Chief Investment Officer at Logos
Dr. Ed Zhong
Investment Advisor at Logos
Dr. Graham Walmsley
Managing Partner at Logos

Frequently asked questions

Who is Graham Walmsley?
Graham Walmsley is a Managing Partner at Logos Capital, where he works on the firm's private investments and structured public investing. He was previously a Principal and Portfolio Manager of the Vantage crossover fund at Versant Ventures, where he served as a board director and helped build biotechnology companies including BlueRock Therapeutics and Akero Therapeutics, and led business development for Jecure Therapeutics. He has authored more than 60 peer-reviewed publications and holds an MD and PhD from Stanford University School of Medicine.
Where does Graham Walmsley work?
Graham Walmsley is Managing Partner at Logos.
What does Graham Walmsley invest in?
Graham Walmsley invests in Biotech.
What boards does Graham Walmsley sit on?
Graham Walmsley holds tracked board seats at Akero Therapeutics, Olema Pharmaceuticals.
What companies has Graham Walmsley invested in?
Investments tracked here include Jecure Therapeutics, BlueRock Therapeutics.
Where did Graham Walmsley go to school?
Graham Walmsley studied at Stanford University School of Medicine (Doctor of Medicine (M.D.)); Stanford University School of Medicine (Doctor of Philosophy (Ph.D.)); University of California, Berkeley (Bachelor of Arts (B.A.), Summa Cum Laude).
Does Graham Walmsley lead rounds?
Yes — Graham Walmsley has led 1 tracked investment.

Same school

Shared employers